<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is the most severe and life-threatening manifestation of human <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e>-a 'neglected' <z:e sem="disease" ids="C1336827" disease_type="Disease or Syndrome" abbrv="">tropical disease</z:e> caused by the protozoan parasite Trypanosoma cruzi </plain></SENT>
<SENT sid="1" pm="."><plain>The disease is endemic in <z:hpo ids='HP_0000001'>all</z:hpo> continental Latin American countries, but has become a worldwide problem because of migration of infected individuals to developed countries, mainly in Europe and North America </plain></SENT>
<SENT sid="2" pm="."><plain>Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> results from the combined effects of persistent parasitism, parasite-driven tissue <z:mp ids='MP_0001845'>inflammation</z:mp>, microvascular and neurogenic dysfunction, and <z:mp ids='MP_0001844'>autoimmune responses</z:mp> triggered by the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical presentation varies widely according to the extent of myocardial damage, and manifests mainly as three basic syndromes that can coexist in an individual patient: <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo>, and <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>NYHA functional class, left ventricular systolic function, and nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> are important prognostic markers of the risk of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Management of Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> focuses on the treatment of the three main syndromes </plain></SENT>
<SENT sid="6" pm="."><plain>The use of Î²-blockers in patients with <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> is safe, well tolerated, and should be encouraged </plain></SENT>
<SENT sid="7" pm="."><plain>Most specialists and international institutions now recommend specific antitrypanosomal treatment of patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e>, even in the absence of evidence obtained from randomized clinical trials </plain></SENT>
<SENT sid="8" pm="."><plain>Further research on the management of patients with Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is necessary </plain></SENT>
</text></document>